Cargando…

Update on Diabetes Mellitus

Diabetes mellitus is a complex multi-system disorder that may be classified as autoimmune mediated type 1 diabetes, or as insulin resistance associated type 2 diabetes. In type 1 diabetes, there is selective loss of the beta cells within the endocrine islets, as a consequence of T-cell and cytokine...

Descripción completa

Detalles Bibliográficos
Autor principal: Korc, Murray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839330/
https://www.ncbi.nlm.nih.gov/pubmed/15502249
http://dx.doi.org/10.1155/2004/945073
_version_ 1782478423390683136
author Korc, Murray
author_facet Korc, Murray
author_sort Korc, Murray
collection PubMed
description Diabetes mellitus is a complex multi-system disorder that may be classified as autoimmune mediated type 1 diabetes, or as insulin resistance associated type 2 diabetes. In type 1 diabetes, there is selective loss of the beta cells within the endocrine islets, as a consequence of T-cell and cytokine mediated destruction of these cells, perhaps in conjunction with destruction of the peri-islet Schwann cells. In type 2 diabetes, the etiology of the resistance ranges from post-receptor defects in the insulin signaling pathway to excessive production of adipocyte derived cytokines that antagonize insulin action to mitochondrial defects that interfere with glucose disposal. Proteome based technologies are providing new insights into these defects.
format Online
Article
Text
id pubmed-3839330
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-38393302013-12-17 Update on Diabetes Mellitus Korc, Murray Dis Markers Other Diabetes mellitus is a complex multi-system disorder that may be classified as autoimmune mediated type 1 diabetes, or as insulin resistance associated type 2 diabetes. In type 1 diabetes, there is selective loss of the beta cells within the endocrine islets, as a consequence of T-cell and cytokine mediated destruction of these cells, perhaps in conjunction with destruction of the peri-islet Schwann cells. In type 2 diabetes, the etiology of the resistance ranges from post-receptor defects in the insulin signaling pathway to excessive production of adipocyte derived cytokines that antagonize insulin action to mitochondrial defects that interfere with glucose disposal. Proteome based technologies are providing new insights into these defects. IOS Press 2004 2004-10-20 /pmc/articles/PMC3839330/ /pubmed/15502249 http://dx.doi.org/10.1155/2004/945073 Text en Copyright © 2004 Hindawi Publishing Corporation.
spellingShingle Other
Korc, Murray
Update on Diabetes Mellitus
title Update on Diabetes Mellitus
title_full Update on Diabetes Mellitus
title_fullStr Update on Diabetes Mellitus
title_full_unstemmed Update on Diabetes Mellitus
title_short Update on Diabetes Mellitus
title_sort update on diabetes mellitus
topic Other
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839330/
https://www.ncbi.nlm.nih.gov/pubmed/15502249
http://dx.doi.org/10.1155/2004/945073
work_keys_str_mv AT korcmurray updateondiabetesmellitus